Market Place
Sourcing Support
Macleod’s Generics Emtricitabine, Tenofovir Receives Nod in US
07 Apr 2026 //
FDA
Teva’ Generics Dapagliflozin And Metformin Receives nod in US
06 Apr 2026 //
FDA
Macleods’ Generics Dapagliflozin & Metformin Receives nod in US
06 Apr 2026 //
FDA
Torrent’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Cipla’s Generics Dapagliflozin & Metformin Receive Approval in US
06 Apr 2026 //
FDA
Cipla’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Msn’s Generics Dapagliflozin & Saxagliptin Receive Approval in US
06 Apr 2026 //
FDA
Lupin’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Aizant’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
MSN’s Generics Dapagliflozin & Metformin Receives Approval in US
06 Apr 2026 //
FDA
MSN’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Bion Pharma’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Aurobindo Pharma’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Micro’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Sandoz’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Baxter’s Generics Phenylephrine HCl Receives Approval in US
03 Apr 2026 //
FDA
Padagis’ Generics Glycopyrronium Tosylate Receives Approval in US
03 Apr 2026 //
FDA
Dr Reddy’s Generics Nintedanib Esylate Receives Approval in US
02 Apr 2026 //
FDA
Cipla’s Generics Nintedanib Esylate Receives Approval in US
02 Apr 2026 //
FDA
Dexcel’s Generics Nintedanib Esylate Receives Approval in US
02 Apr 2026 //
FDA
Apotex’s Generics Nintedanib Esylate Receives Approval in US
02 Apr 2026 //
FDA
Sagent’s Generics Norepinephrine Receives Approval in US
26 Mar 2026 //
FDA
Lupin’s Generics Sugammadex Receives Tentative Approval in US
26 Mar 2026 //
FDA
Teva’s Generics Nintedanib Receives Tentative Approval in US
26 Mar 2026 //
FDA
Glenmark’ Generics Nintedanib Receives Tentative Approval in US
26 Mar 2026 //
FDA
Inventia’s Generics Sitagliptin Receives Tentative Approval in US
25 Mar 2026 //
FDA
Natco’s Generics Cabozantinib Receives Tentative Approval in US
25 Mar 2026 //
FDA
Corcept Therap’s Lifyorlitm Receives Approval in Us
25 Mar 2026 //
FDA
Encube’s Generics Tretinoin Receives Approval in US
25 Mar 2026 //
FDA
Alkem’s Generics Zonisamide Receives Tentative Approval in US
24 Mar 2026 //
FDA
Novitium’s Generics Pitolisant Receives Tentative Approval in US
24 Mar 2026 //
FDA
Sun’s Generics Pomalidomide Receives Tentative Approval in US
24 Mar 2026 //
FDA
Denali’s Biologics Avlayah Receives Approval in US
24 Mar 2026 //
FDA
Ascent Pharms’ Generics Guanfacine HCl Receives Approval in US
24 Mar 2026 //
FDA
Unique’s Generics Bisoprolol Fumarate Receives Approval in US
24 Mar 2026 //
FDA
Zhejiang Jingxin’s Generics Ticagrelor Receives Approval in US
24 Mar 2026 //
FDA
Torrent’s Generics Ruxolitinib Receives Tentative Approval in US
23 Mar 2026 //
FDA
Qilu’s Generics Revefenacin Receives Tentative Approval in US
23 Mar 2026 //
FDA
Lupin’s Generics Pitolisant Receives Tentative Approval in US
23 Mar 2026 //
FDA
Macleods Pharms’ Generics Mexiletine HCl Receives Approval in US
23 Mar 2026 //
FDA
Rising’s Generics Clindamycin Phosphate Receives Approval in US
23 Mar 2026 //
FDA
Aurobindo Pharma’s Generics Cefixime Receives Approval in US
23 Mar 2026 //
FDA
Alkem’s Generics Rifaximin Receives Tentative Approval in US
20 Mar 2026 //
FDA
Annora’s Generics Gabapentin Receives Tentative Approval in US
20 Mar 2026 //
FDA
Map77’s Atoncy Receives Approval in US
20 Mar 2026 //
FDA
Quagen’s Generics Lidocaine HCl Receives Approval in US
20 Mar 2026 //
FDA
Viwit Pharm’s Generics Lidocaine HCl Receives Approval in US
19 Mar 2026 //
FDA
Freseni Kabi’s Generics Ephedrine Sulfate Receives Approval in US
19 Mar 2026 //
FDA
Amneal Pharms’s Kitprozy Receives Tentative Approval in US
19 Mar 2026 //
FDA
Micro’s Generics Valganciclovir HCl Receives Approval in US
19 Mar 2026 //
FDA
Deproco’s Flavalta Receives Approval in US
19 Mar 2026 //
FDA
I3 Pharms’ Generics Rifabutin Receives Approval in US
19 Mar 2026 //
FDA
Actavis’s Generics Rifaximin Receives Approval in US
19 Mar 2026 //
FDA
Natco’s Generics Palbociclib Receives Tentative Approval in US
19 Mar 2026 //
FDA
Annora’s Generics Desogestrel & Estradiol Receives Approval in US
18 Mar 2026 //
FDA
Aurobindo’s Generics Clindamycin Receives Approval in US
18 Mar 2026 //
FDA
Dr Reddy’s Generics Sugammadex Receives Tentative Approval in US
18 Mar 2026 //
FDA
Biocon’s Generics Cabozantinib Receives Tentative Approval in US
17 Mar 2026 //
FDA
Qilu’s Generics Nintedanib Receives Tentative Approval in US
17 Mar 2026 //
FDA
Aspiro’s Generics Micafungin Na Receives Approval in US
17 Mar 2026 //
FDA
